Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency

J Clin Invest. 2012 Jan;122(1):315-26. doi: 10.1172/JCI42534. Epub 2011 Dec 12.

Abstract

Ectodermal dysplasia with immune deficiency (EDI) is an immunological and developmental disorder caused by alterations in the gene encoding NF-κB essential modulator (NEMO; also known as IκB kinase γ subunit [IKKγ]). Missense mutations in the gene encoding NEMO are associated with reduced signal-induced nuclear translocation of NF-κB proteins, resulting in defective expression of NF-κB target genes. Here, we report 2 unrelated male patients with EDI, both of whom have normal NEMO coding sequences, but exhibit a marked reduction in expression of full-length NEMO protein. TLR4 stimulation of APCs from these patients induced normal cytoplasmic activation and nuclear translocation of NF-κB. However, cells deficient in full-length NEMO were defective in expression of NF-κB-regulated cytokines, such as IL-12, suggesting a downstream defect in chromatin accessibility for NF-κB transcription factors. TLR4-stimulated APCs from the patients were defective in IKKα-dependent H3 histone phosphorylation at the IL-12 promoter and recruitment of NF-κB heterodimers RelA and cRel to the promoter. Expression of a super-active form of IKKα restored IL-12 production in a NEMO knockdown human monocytic cell line following LPS treatment. Our findings suggest that NEMO regulates the nuclear function of IKKα and offer new insights into the mechanisms underlying diminished NF-κB signaling in patients with EDI.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cell Line
  • Cell Nucleus / metabolism
  • Child, Preschool
  • Cytokines / genetics
  • Cytokines / metabolism
  • DNA-Binding Proteins / metabolism
  • Ectodermal Dysplasia / genetics
  • Ectodermal Dysplasia / immunology*
  • Ectodermal Dysplasia / metabolism*
  • Gene Expression
  • Gene Knockdown Techniques
  • Gene Rearrangement
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / immunology*
  • Genetic Diseases, X-Linked / metabolism*
  • Humans
  • I-kappa B Kinase / antagonists & inhibitors
  • I-kappa B Kinase / genetics
  • I-kappa B Kinase / metabolism*
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / metabolism*
  • Interleukin-12 / genetics
  • Interleukin-12 / metabolism
  • MAP Kinase Signaling System
  • Male
  • Monocytes / immunology
  • Monocytes / metabolism
  • NF-kappa B / metabolism
  • Nuclear Proteins / metabolism
  • Primary Immunodeficiency Diseases
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins c-rel
  • Signal Transduction
  • Toll-Like Receptor 4 / metabolism
  • Transcription Factor RelA / metabolism

Substances

  • Cytokines
  • DNA-Binding Proteins
  • IKBKG protein, human
  • NF-kappa B
  • Nuclear Proteins
  • Proto-Oncogene Proteins c-rel
  • REL protein, human
  • RELA protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 4
  • Transcription Factor RelA
  • Interleukin-12
  • I-kappa B Kinase

Supplementary concepts

  • NEMO mutation with immunodeficiency